Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine, azithromycin, and zinc for treatment of COVID-19 in Senegal
PACTR202005622389003Phase 3Not yet recruiting
- Sponsor
- Cheikh Anta Diop University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in coronavirus disease 2019 (COVID-19) comparing Hydroxychloroquine + azithromycin with Hydroxychloroquine + azithromycin + zinc (2 arms). Primary endpoint: Undetectable viral load at day 7. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
hydroxychloroquineazithromycinzinc
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on PACTR202005622389003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202005622389003.